Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

117.28
-1.3500-1.14%
Post-market: 117.280.00000.00%19:30 EDT
Volume:591.62K
Turnover:69.49M
Market Cap:9.75B
PE:-36.51
High:119.26
Open:118.63
Low:115.55
Close:118.63
52wk High:130.05
52wk Low:40.10
Shares:83.15M
Float Shares:64.87M
Volume Ratio:0.92
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2122
EPS(LYR):-3.6900
ROE:-24.15%
ROA:-15.59%
PB:6.46
PE(LYR):-31.78

Loading ...

Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Aug 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 19, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 03, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]